Influenza Vaccines: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • ID: 3797461
  • Drug Pipelines
  • 99 pages
  • Datamonitor Healthcare
1 of 3
The seasonal influenza vaccines market will be boosted by the broadening of vaccination recommendations within the EU markets to include school-aged children, and the gradual adoption of premium-priced quadrivalent influenza vaccines (QIVs).

This report addresses the following questions:

- How will new and changing recommendations impact vaccines sales?
- How will vaccination coverage rates for influenza change over the forecast period?
- Which factors will be drivers and resistors of uptake for novel QIVs?
- Which vaccine approaches have the greatest potential to improve protection for infants and the elderly?
- How will the launches of adjuvanted and virus-like particle QIVs affect the landscape of the seasonal influenza vaccines market?
Note: Product cover images may vary from those shown
2 of 3
FORECAST: SEASONAL INFLUENZA VACCINES

- Executive Summary
- Market Overview and Trends
- Market Definition
- Key Drivers and Resistors of Conversion To QIVs
- US Market Forecast
- France Market Forecast
- Germany Market Forecast
- Italy Market Forecast
- Spain Market Forecast
- UK Market Forecast
- Key Opinion Leader Research

PIPELINE: SEASONAL INFLUENZA VACCINES

- Executive Summary
- Clinical Pipeline Overview
- Product profile (late stage): MF-
- adjuvanted QIV
- Product profile (late stage): VLP QIV
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll